Emerging Roles of Circular RNA in Macrophage Activation and Inflammatory Lung Responses.

Autor: Son, Chang Jun¹ (AUTHOR) cjson@bu.edu, Carnino, Jonathan M.¹ (AUTHOR) jcarnino@bu.edu, Lee, Heedoo^1,2 (AUTHOR) leehd@changwon.ac.kr, Jin, Yang¹ (AUTHOR) yjin1@bu.edu

Publikováno v: Cells (2073-4409). Sep2024, Vol. 13 Issue 17, p1407. 13p.

Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the Literature.

Autor: Gioia, Chiara¹ (AUTHOR) chiara.gioia@uniroma1.it, Paroli, Marino¹ (AUTHOR), Izzo, Raffaella¹ (AUTHOR), Di Sanzo, Lorenzo¹ (AUTHOR), Rossi, Elisabetta¹ (AUTHOR), Pignatelli, Pasquale¹ (AUTHOR), Accapezzato, Daniele¹ (AUTHOR) daniele.accapezzato@uniroma1.it

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p5921. 11p.

TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway.

Autor: Wang, Haidong¹ (AUTHOR), Lou, Jun¹ (AUTHOR), Liu, Hao² (AUTHOR), Liu, Yunlong¹ (AUTHOR), Xie, Binbin¹ (AUTHOR), Zhang, Wei¹ (AUTHOR), Xie, Jiansheng² (AUTHOR), Pan, Hongming¹ (AUTHOR) panhongming@zju.edu.cn, Han, Weidong^1,3 (AUTHOR) hanwd@zju.edu.cn

Publikováno v: Scientific Reports. 7/11/2024, Vol. 14 Issue 1, p1-13. 13p.

Plonmarlimab, a novel anti-GM-CSF blocking antibody, ameliorates disease progression in the pre-clinical model of macrophage activation syndrome.

Autor: Ding J; TJ Biopharma, Co., Ltd., Hangzhou, China., Xu K; TJ Biopharma, Co., Ltd., Hangzhou, China., Niu Y; TJ Biopharma, Co., Ltd., Hangzhou, China., Qin Y; TJ Biopharma, Co., Ltd., Hangzhou, China., Shen H; Zhejiang Institute for Food and Drug Control, Hangzhou, China., Wang Y; TJ Biopharma, Co., Ltd., Hangzhou, China., Guo W; TJ Biopharma, Co., Ltd., Hangzhou, China., Liu X; TJ Biopharma, Co., Ltd., Hangzhou, China., Wang Z; TJ Biopharma, Co., Ltd., Hangzhou, China., Zhu AX; TJ Biopharma, Co., Ltd., Hangzhou, China.

Publikováno v: Immunology [Immunology] 2024 Nov; Vol. 173 (3), pp. 552-561. Date of Electronic Publication: 2024 Aug 02.

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy.

Autor: Ulu K; Department of Pediatric Rheumatology, Ümraniye Training and Research Hospital, İstanbul, Turkey., Aliyev E; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey., Kılıç Könte E; Department of Pediatric Rheumatology, İstanbul University-Cerrahpasa, İstanbul, Turkey., Tanatar A; Department of Pediatric Rheumatology, İstanbul University, İstanbul, Turkey., Türkmen Ş; Department of Pediatric Rheumatology, Ümraniye Training and Research Hospital, İstanbul, Turkey., Doğantan Ş; Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey., Kızıldağ Z; Department of Pediatric Rheumatology, Dokuz Eylül University, İzmir, Turkey., Kasap Demir B; Department of Pediatric Rheumatology, Tepecik Training and Research Hospital, İzmir, Turkey., Gezgin Yıldırım D; Department of Pediatric Rheumatology, Gazi University, Ankara, Turkey., Otar Yener G; Department of Pediatric Rheumatology, Gaziantep Medical Point Hospital, Gaziantep, Turkey., Öztürk K; Department of Pediatric Rheumatology, İstanbul Medeniyet University, İstanbul, Turkey., Baba Ö; Department of Pediatric Rheumatology, Karadeniz Technical University, Trabzon, Turkey., Açarı C; Department of Pediatric Rheumatology, İnönü University, Malatya, Turkey., Kılbaş G; Department of Pediatric Rheumatology, Pamukkale University, Denizli, Turkey., Taşkın SN; Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey., Haşlak F; Department of Pediatric Rheumatology, İstanbul University-Cerrahpasa, İstanbul, Turkey., Çağlayan Ş; Department of Pediatric Rheumatology, Ümraniye Training and Research Hospital, İstanbul, Turkey., Bağlan E; Department of Pediatric Rheumatology, Dr Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey., Dundar HA; Department of Pediatric Rheumatology, Van Training and Research Hospital, Van, Turkey., Başaran Ö; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey., Barut K; Department of Pediatric Rheumatology, İstanbul University-Cerrahpasa, İstanbul, Turkey., Karadağ ŞG; Department of Pediatric Rheumatology, İstanbul University, İstanbul, Turkey., Coşkuner T; Department of Pediatric Rheumatology, Ümraniye Training and Research Hospital, İstanbul, Turkey., Sönmez HE; Department of Pediatric Rheumatology, Kocaeli University, Kocaeli, Turkey., Yüksel S; Department of Pediatric Rheumatology, Pamukkale University, Denizli, Turkey., Kalyoncu M; Department of Pediatric Rheumatology, Karadeniz Technical University, Trabzon, Turkey., Bakkaloğlu SA; Department of Pediatric Rheumatology, Gazi University, Ankara, Turkey., Ünsal E; Department of Pediatric Rheumatology, Dokuz Eylül University, İzmir, Turkey., Paç Kısaarslan A; Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey., Bilginer Y; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey., Aktay Ayaz N; Department of Pediatric Rheumatology, İstanbul University, İstanbul, Turkey., Kasapçopur Ö; Department of Pediatric Rheumatology, İstanbul University-Cerrahpasa, İstanbul, Turkey., Özen S; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey., Sözeri B; Department of Pediatric Rheumatology, Ümraniye Training and Research Hospital, İstanbul, Turkey.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Sep 01; Vol. 63 (SI2), pp. SI167-SI172.